TCGA liver hepatocellular carcinoma (LIHC) reverse phase protein array

TCGA liver hepatocellular carcinoma (LIHC) segmented copy number

TCGA liver hepatocellular carcinoma (LIHC) exon expression by RNAseq (polyA+ IlluminaHiSeq)

{"cgdataversion":1,"owner":"TCGA","longTitle":"TCGA liver hepatocellular carcinoma (LIHC) PARADIGM inference activity (RNAseq)","cohort":"TCGA Liver Cancer (LIHC)","url":"http://gdac.broadinstitute.org/runs/analyses__2016_01_28/data/LIHC/20160128/","probeMap":"paradigmPathwayV1.probeMap","dataSubType":"PARADIGM pathway activity","security":"public","label":"expression","tags":["cancer"],"path":"data/public/TCGA/LIHC/Pathway_Paradigm_RNASeq","anatomical_origin":["Liver"],"name":"TCGA.LIHC.sampleMap/Pathway_Paradigm_RNASeq","dataproducer":"TCGA FIREHOSE pipeline","wrangling_procedure":"FIREHOSE data download from TCGA DCC, processed at UCSC into cgData repository","sample_type":["tumor"],"redistribution":true,"domain":"TCGA","groupTitle":"TCGA liver hepatocellular carcinoma","type":"genomicMatrix","wrangler":"cgData TCGAscript Pathway_Paradigm processed on 2017-09-08","version":"2017-09-08","primary_disease":"liver hepatocellular carcinoma","description":"Broad FireHose automated run results of TCGA liver hepatocellular carcinoma (LIHC) gene activity level inferred using the PARADIGM method on RNAseq data alone.<br><br>PARADIGM (PMID 20529912) is pathway analysis method to infer tumor sample-specific genetic activities by incorporating curated pathway interactions as well as integrating diverse types of genomic data. The pathways used in this analysis are from <a href=\"http://pid.nci.nih.gov/\" target=\"_blank\"><u>NCI pathway interaction database</u></a>.<br><br>"}

TCGA liver hepatocellular carcinoma (LIHC) PARADIGM inference activity (RNAseq)

{"cgdataversion":1,"owner":"TCGA","longTitle":"TCGA liver hepatocellular carcinoma (LIHC) PARADIGM inference activity (RNAseq + CNV)","cohort":"TCGA Liver Cancer (LIHC)","url":"http://gdac.broadinstitute.org/runs/analyses__2016_01_28/data/LIHC/20160128/","probeMap":"paradigmPathwayV1.probeMap","dataSubType":"PARADIGM pathway activity","security":"public","label":"expression + CNV","tags":["cancer"],"path":"data/public/TCGA/LIHC/Pathway_Paradigm_RNASeq_And_Copy_Number","anatomical_origin":["Liver"],"name":"TCGA.LIHC.sampleMap/Pathway_Paradigm_RNASeq_And_Copy_Number","dataproducer":"TCGA FIREHOSE pipeline","wrangling_procedure":"FIREHOSE data download from TCGA DCC, processed at UCSC into cgData repository","sample_type":["tumor"],"redistribution":true,"domain":"TCGA","groupTitle":"TCGA liver hepatocellular carcinoma","type":"genomicMatrix","wrangler":"cgData TCGAscript Pathway_Paradigm processed on 2017-09-08","version":"2017-09-08","primary_disease":"liver hepatocellular carcinoma","description":"Broad FireHose automated run results of TCGA liver hepatocellular carcinoma (LIHC) gene activity level inferred using the PARADIGM method by integrating RNAseq and copy number data.<br><br>PARADIGM (PMID 20529912) is pathway analysis method to infer tumor sample-specific genetic activities by incorporating curated pathway interactions as well as integrating diverse types of genomic data. The pathways used in this analysis are from <a href=\"http://pid.nci.nih.gov/\" target=\"_blank\"><u>NCI pathway interaction database</u></a>.<br><br>"}